Nutriband (NTRB) announced that it has received notification that its patent has been granted in Macao for its patent entitled, “Abuse and Misuse Deterrent Transdermal Systems,” which protects its AVERSA abuse deterrent transdermal technology. The Macao Intellectual Property Office granted patent J/9010 on February 11, 2025 as recorded in Macao Official Bulletin No. 10 on March 5, 2025. Macao is a Special Administrative Region of the People’s Republic of China that has its own patent system and patent laws which are separate and distinct from those of mainland China.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRB:
- Nutriband Partners with Charlotte FC for Brand Visibility
- Nutriband signs partnership agreement with Charlotte FC
- Nutriband receives Certificate of Registration from USPTO for trademark
- Nutriband Expands Partnership with Kindeva for Aversa™
- Nutriband, Kindeva Drug Delivery formalize exclusive development partnership
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue